Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
IceCure Medical Ltd. stock logo
ICCM
IceCure Medical
$0.95
+0.1%
$1.06
$0.48
$1.66
$52.73M0.33469,069 shs199,619 shs
Meihua International Medical Technologies Co., Ltd. stock logo
MHUA
Meihua International Medical Technologies
$0.40
-3.6%
$0.37
$0.25
$1.47
$13.08M0.85688,902 shs88,931 shs
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
$4.73
-0.2%
$4.68
$4.01
$9.33
$77.95M1.32194,415 shs55,435 shs
Neuronetics, Inc. stock logo
STIM
Neuronetics
$3.46
+2.4%
$4.03
$0.52
$5.92
$222.47M1.92776,204 shs1.06 million shs
The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
IceCure Medical Ltd. stock logo
ICCM
IceCure Medical
0.00%-4.04%-6.86%-24.00%+20.41%
Meihua International Medical Technologies Co., Ltd. stock logo
MHUA
Meihua International Medical Technologies
0.00%+7.87%+6.69%+19.89%-51.49%
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
0.00%-4.63%-1.25%+0.64%-8.14%
Neuronetics, Inc. stock logo
STIM
Neuronetics
0.00%-11.29%-21.21%-30.45%+85.71%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
IceCure Medical Ltd. stock logo
ICCM
IceCure Medical
2.4576 of 5 stars
3.85.00.00.00.60.00.6
Meihua International Medical Technologies Co., Ltd. stock logo
MHUA
Meihua International Medical Technologies
N/AN/AN/AN/AN/AN/AN/AN/A
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
1.4684 of 5 stars
3.62.00.00.01.80.00.0
Neuronetics, Inc. stock logo
STIM
Neuronetics
2.3448 of 5 stars
3.32.00.00.02.71.70.6
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
IceCure Medical Ltd. stock logo
ICCM
IceCure Medical
3.50
Strong Buy$2.50162.83% Upside
Meihua International Medical Technologies Co., Ltd. stock logo
MHUA
Meihua International Medical Technologies
0.00
N/AN/AN/A
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
3.25
Buy$11.67146.65% Upside
Neuronetics, Inc. stock logo
STIM
Neuronetics
2.67
Moderate Buy$5.5058.96% Upside

Current Analyst Ratings Breakdown

Latest SRTS, MHUA, ICCM, and STIM Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/29/2025
IceCure Medical Ltd. stock logo
ICCM
IceCure Medical
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$2.50
5/19/2025
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
Maxim Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$14.00 ➝ $10.00
4/4/2025
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$12.00 ➝ $12.00
3/28/2025
IceCure Medical Ltd. stock logo
ICCM
IceCure Medical
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$2.50 ➝ $2.50
(Data available from 6/20/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
IceCure Medical Ltd. stock logo
ICCM
IceCure Medical
$3.29M16.05N/AN/A$0.12 per share7.93
Meihua International Medical Technologies Co., Ltd. stock logo
MHUA
Meihua International Medical Technologies
$96.90M0.13$0.44 per share0.90$6.34 per share0.06
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
$41.81M1.86$0.43 per share10.97$3.41 per share1.39
Neuronetics, Inc. stock logo
STIM
Neuronetics
$74.89M3.04N/AN/A$0.57 per share6.07
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
IceCure Medical Ltd. stock logo
ICCM
IceCure Medical
-$15.32M-$0.28N/AN/AN/A-467.37%-182.26%-112.65%8/19/2025 (Estimated)
Meihua International Medical Technologies Co., Ltd. stock logo
MHUA
Meihua International Medical Technologies
$10.84MN/A0.00N/AN/AN/AN/AN/A
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
$6.65M$0.1047.3020.57N/A4.56%3.34%3.00%8/6/2025 (Estimated)
Neuronetics, Inc. stock logo
STIM
Neuronetics
-$43.71M-$1.31N/AN/AN/A-53.67%-174.15%-38.41%8/11/2025 (Estimated)

Latest SRTS, MHUA, ICCM, and STIM Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/28/2025Q1 2025
IceCure Medical Ltd. stock logo
ICCM
IceCure Medical
-$0.08-$0.06+$0.02-$0.06$0.75 million$0.73 million
5/15/2025Q1 2025
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
$0.04-$0.16-$0.20-$0.16$7.23 million$8.34 million
5/6/2025Q1 2025
Neuronetics, Inc. stock logo
STIM
Neuronetics
-$0.13-$0.21-$0.08-$0.21$29.07 million$31.98 million
3/27/2025Q4 2024
IceCure Medical Ltd. stock logo
ICCM
IceCure Medical
-$0.07-$0.08-$0.01-$0.08$1.07 million$1.07 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
IceCure Medical Ltd. stock logo
ICCM
IceCure Medical
N/AN/AN/AN/AN/A
Meihua International Medical Technologies Co., Ltd. stock logo
MHUA
Meihua International Medical Technologies
N/AN/AN/AN/AN/A
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
N/AN/AN/AN/AN/A
Neuronetics, Inc. stock logo
STIM
Neuronetics
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
IceCure Medical Ltd. stock logo
ICCM
IceCure Medical
0.02
1.89
1.48
Meihua International Medical Technologies Co., Ltd. stock logo
MHUA
Meihua International Medical Technologies
N/A
5.26
5.21
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
N/A
8.06
5.74
Neuronetics, Inc. stock logo
STIM
Neuronetics
1.40
2.44
2.28

Institutional Ownership

CompanyInstitutional Ownership
IceCure Medical Ltd. stock logo
ICCM
IceCure Medical
0.62%
Meihua International Medical Technologies Co., Ltd. stock logo
MHUA
Meihua International Medical Technologies
1.17%
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
25.30%
Neuronetics, Inc. stock logo
STIM
Neuronetics
53.59%
CompanyEmployeesShares OutstandingFree FloatOptionable
IceCure Medical Ltd. stock logo
ICCM
IceCure Medical
6055.50 million54.15 millionNot Optionable
Meihua International Medical Technologies Co., Ltd. stock logo
MHUA
Meihua International Medical Technologies
62031.90 million10.67 millionNot Optionable
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
4016.44 million14.98 millionOptionable
Neuronetics, Inc. stock logo
STIM
Neuronetics
18065.82 million60.09 millionOptionable

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

IceCure Medical stock logo

IceCure Medical NASDAQ:ICCM

$0.95 +0.00 (+0.13%)
Closing price 03:56 PM Eastern
Extended Trading
$0.98 +0.03 (+3.55%)
As of 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

IceCure Medical Ltd, a commercial stage medical device company, engages in the research, development, and marketing of cryoablation systems, disposables, and technologies for treating tumors. The company offers ProSense system, a single probe system for the treatment of tumors, as well as associated disposables; and IceSense3 system for ablation indications to urology, oncology, dermatology, gynecology, general surgery, thoracic surgery, and proctology. It also develops XSense system, a single probe system; and MultiSense, a multi probe system for the treatment of multiple and larger tumors. The company was incorporated in 2006 and is headquartered in Caesarea, Israel.

Meihua International Medical Technologies stock logo

Meihua International Medical Technologies NASDAQ:MHUA

$0.40 -0.01 (-3.64%)
Closing price 03:09 PM Eastern
Extended Trading
$0.38 -0.02 (-5.06%)
As of 06:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Meihua International Medical Technologies Co., Ltd. engages in the manufacture, sells, and marketing of medical consumables in the People's Republic of China. The company offers class I, II, and III disposable medical devices. Its products include non-bottled products, such as brushes and ID bracelets; and polyethylene bottled products, such as eye drop and tablet bottles, as well as electronic pumps. The company also distributes disposable medical devices sourced from other manufacturers to customers in China. In addition, it offers COVID-19 products comprising disposable medical masks. The company serves hospitals, pharmacies, medical institutions, and medical equipment companies. It also exports its products to Europe, North America, South America, Asia, Africa, and Oceania. The company was founded in 1991 and is based in Yangzhou, the People's Republic of China. Meihua International Medical Technologies Co., Ltd. operates as a subsidiary of Bright Accomplish Limited.

Sensus Healthcare stock logo

Sensus Healthcare NASDAQ:SRTS

$4.73 -0.01 (-0.21%)
Closing price 04:00 PM Eastern
Extended Trading
$4.71 -0.02 (-0.42%)
As of 04:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Sensus Healthcare, Inc., a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy, a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. The company also provides SRT-100 Plus; Sentinel service program, which offers its customers protection for their systems; and Transdermal Infusion system, a biophysical alternative to infuse high weight molecule modalities into the dermis for medical and aesthetic purposes without the use of needles. In addition, it sells disposable lead shielding replacements; and disposable radiation safety items, such as aprons and eye shields, ultrasound probe film, and disposable applicator tips to treat various sized lesions and various areas of the body. Further, the company distributes laser devices, which includes applications for hair removal, vascular lesions, acne treatment, skin toning, and skin rejuvenation, as well as epidermal pigment removal for spots, freckles, and tattoos. It markets its products primarily to private dermatology practices, and radiation oncologists in both private and hospital settings. Sensus Healthcare, Inc. was incorporated in 2010 and is headquartered in Boca Raton, Florida.

Neuronetics stock logo

Neuronetics NASDAQ:STIM

$3.46 +0.08 (+2.37%)
Closing price 04:00 PM Eastern
Extended Trading
$3.67 +0.21 (+6.04%)
As of 07:53 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrists. The company was incorporated in 2001 and is headquartered in Malvern, Pennsylvania.